好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effectiveness and safety of fingolimod in Spanish Relapsing-Remitting Multiple Sclerosis patients in clinical practice (Fingoview study): Subanalysis of patients previously treated with first line injectable disease-modifying treatment
Multiple Sclerosis
P6 - (-)
371
Authors/Disclosures

PRESENTER
No disclosure on file
Francisco Barrero No disclosure on file
Eugenia Marzo No disclosure on file
Javier Jose Mallada Frechin No disclosure on file
Virginia Meca Lallana Virginia Meca Lallana has nothing to disclose.
Carmen Duran Herrera (Grupo 7 Viajes) No disclosure on file
Teresa Ayuso, MD (Hospital de Navarra) No disclosure on file
Jose Meca Lallana, MD (Hospital Clinico Universitario Virgen De La Arrixaca) Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Sergio Martinez-Yelamos, MD No disclosure on file
MARIA JOSE MORENO JIMENEZ No disclosure on file
No disclosure on file
Francisco Javier Ricart Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis. Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis.
No disclosure on file